Porcine Epidemic Diarrhea Vaccines Market 2024 - Outlook, Overview And Competitor Analysis 2033

"The Business Research Company recently released a comprehensive report on the Global Porcine Epidemic Diarrhea Vaccines Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

According to The Business Research Company's, The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to large-scale vaccination campaigns, expanded programs on immunization (EPI), the adoption of disposable syringes, diarrhea eradication efforts, and initiatives like the global alliance for vaccines and immunization (GAVI).

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Market Drivers and Trends:

The increasing pig farming is expected to propel the growth of the porcine epidemic diarrhea vaccines market going forward. Pig farming involves raising domestic pigs for meat production, breeding, rearing, managing from birth to market weight, and marketing and selling pork products. Pig farming is increasing due to rising global demand for pork products, improvements in breeding and management practices, technological advancements in farming techniques, and expanding markets for pork consumption. Porcine epidemic diarrhea (PED) vaccines are employed in pig farming to prevent and manage outbreaks. They are usually administered via injection or orally starting from the sow's gestation period to confer passive immunity to newborn piglets through colostrum. For instance, in December 2023, according to the United States Department of Agriculture, a US-based government department, around 75.0 million hogs and pigs were raised on American farms as of December 2023. Furthermore, in January 2022, according to the Department for Environment, Food & Rural Affairs, a UK-based government organization, pork on agricultural holdings increased to 4.08 million in December 2021 from 3.74 million in December 2020, a 9% rise. Therefore, the increasing pig farming is driving the growth of the porcine epidemic diarrhea vaccines market.

Major companies operating in the porcine epidemic diarrhea vaccines market are developing innovative products, such as the porcine parvovirus (PPV) vaccine, to strengthen their position in the market. The Porcine Parvovirus (PPV) vaccine is a veterinary immunization designed to prevent reproductive failure in pigs caused by PPV, a small, non-enveloped virus associated with infertility, stillbirths, mummified fetuses, and weak piglets. For instance, in March 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine. This innovative vaccine is designed to combat reproductive failure in pigs, including infertility, stillbirths, mummified fetuses, and weak piglets caused by PPV, a small, non-enveloped virus. The uniqueness of this launch lies in the advanced formulation and efficacy of the vaccine, which offers comprehensive protection against PPV-induced reproductive losses, thereby safeguarding the health and productivity of pig herds.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd.,Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc

Porcine Epidemic Diarrhea Vaccines Market 2024 Key Insights:

• The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.
• Driving Factors Behind The Growth Of Porcine Epidemic Diarrhea Vaccines Market
• Innovative Porcine Parvovirus (PPV) Vaccines To Combat Reproductive Failure In Pigs

• Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=16514&type=smp

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.